(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
3 days till quarter result
(bmo 2024-05-14)
Expected move: +/- 16.18%
@ $2.97
Issued: 14 Feb 2024 @ 09:30
Return: -40.72%
Previous signal: Feb 13 - 12:28
Previous signal:
Return: 2.92 %
Live Chart Being Loaded With Signals
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology...
Stats | |
---|---|
Today's Volume | 1.94M |
Average Volume | 1.85M |
Market Cap | 260.93M |
EPS | $0 ( 2024-05-09 ) |
Next earnings date | ( $-0.120 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.91 |
ATR14 | $0.00400 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-10 | Schmid John P. | Buy | 5 400 | Common Stock |
2024-03-15 | Sherman Jeffrey W | Buy | 6 502 | Common Stock |
2024-03-15 | Kong Garheng | Buy | 6 474 | Common Stock |
2024-03-15 | Johnson John | Buy | 89 571 | Common Stock |
2024-03-18 | Johnson John | Buy | 215 600 | Common Stock |
INSIDER POWER |
---|
92.66 |
Last 99 transactions |
Buy: 12 197 840 | Sell: 238 056 |
Volume Correlation
Xeris Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
IRWD | 0.917 |
WRAP | 0.87 |
ZS | 0.866 |
GTEC | 0.857 |
TELA | 0.854 |
NEPH | 0.852 |
DLHC | 0.852 |
ASUR | 0.842 |
MFH | 0.841 |
PGNY | 0.84 |
10 Most Negative Correlations | |
---|---|
TLMD | -0.886 |
EPZM | -0.862 |
RING | -0.832 |
SLVO | -0.829 |
XOG | -0.828 |
CNCE | -0.827 |
RMRM | -0.819 |
SIVBP | -0.817 |
MGEE | -0.812 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Xeris Pharmaceuticals Inc Correlation - Currency/Commodity
Xeris Pharmaceuticals Inc Financials
Annual | 2024 |
Revenue: | $163.91M |
Gross Profit: | $124.43M (75.91 %) |
EPS: | $-0.450 |
FY | 2024 |
Revenue: | $163.91M |
Gross Profit: | $124.43M (75.91 %) |
EPS: | $-0.450 |
FY | 2023 |
Revenue: | $110.25M |
Gross Profit: | $87.61M (79.47 %) |
EPS: | $-0.700 |
FY | 2022 |
Revenue: | $110.25M |
Gross Profit: | $87.61M (79.47 %) |
EPS: | $-1.200 |
Financial Reports:
No articles found.
Xeris Pharmaceuticals Inc
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators